Moderna Inc (MRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 1,944,000 | 3,236,000 | 6,848,000 | 19,263,000 | 18,471,000 |
| Cost of Goods | 868,000 | 1,464,000 | 4,693,000 | 5,416,000 | 2,617,000 |
| Gross Profit | 1,076,000 | 1,772,000 | 2,155,000 | 13,847,000 | 15,854,000 |
| Operating Expenses | 4,150,000 | 5,717,000 | 6,394,000 | 4,427,000 | 2,558,000 |
| Operating Income | -3,074,000 | -3,945,000 | -4,239,000 | 9,420,000 | 13,296,000 |
| Other Income | 306,000 | 338,000 | 297,000 | 155,000 | -11,000 |
| Pre-tax Income | -2,768,000 | -3,607,000 | -3,942,000 | 9,575,000 | 13,285,000 |
| Income Tax | 54,000 | -46,000 | 772,000 | 1,213,000 | 1,083,000 |
| Net Income Continuous | -2,822,000 | -3,561,000 | -4,714,000 | 8,362,000 | 12,202,000 |
| Net Income | $-2,822,000 | $-3,561,000 | $-4,714,000 | $8,362,000 | $12,202,000 |
| EPS Basic Total Ops | -7.26 | -9.28 | -12.33 | 21.26 | 30.31 |
| EPS Basic Continuous Ops | -7.25 | -9.27 | -12.34 | 21.22 | 30.28 |
| EPS Diluted Total Ops | -7.26 | -9.28 | -12.33 | 20.12 | 28.29 |
| EPS Diluted Continuous Ops | -7.25 | -9.27 | -12.34 | 20.10 | 28.31 |
| EPS Diluted Before Non-Recurring Items | -7.26 | -8.87 | -12.33 | 20.12 | 28.29 |
| EBITDA(a) | $-2,926,000 | $-3,851,000 | $-3,679,000 | $9,799,000 | $13,582,000 |